DARE BIOSCIENCE INC(NASDAQ:DARE) stock News

DARE Latest News, Press Relases and Analysis

All

Press Releases

10 days ago - By: Daré Bioscience, Inc.

Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research

a month ago - By: Benzinga - Mentions: CHRS CPRT EAT LDOS

This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

2 months ago - By: Zacks Investment Research - Mentions: AUNA

Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates

2 months ago - By: Benzinga - Mentions: TRIB UNH ONMD PAHC ...

12 Health Care Stocks Moving In Thursday's After-Market Session

2 months ago - By: The Motley Fool

Daré Bioscience Posts Narrower Q2 Loss

2 months ago - By: Daré Bioscience, Inc.

Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update

4 months ago - By: Daré Bioscience, Inc.

Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders

2 months ago - By: Zacks Investment Research - Mentions: IMTX

Immatics (IMTX) Reports Q2 Loss, Misses Revenue Estimates

2 months ago - By: Zacks Investment Research - Mentions: EDIT

Editas Medicine (EDIT) Reports Q2 Loss, Tops Revenue Estimates

2 months ago - By: Zacks Investment Research - Mentions: CCCC

C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates

2 months ago - By: Daré Bioscience, Inc.

Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025

2 months ago - By: Zacks Investment Research - Mentions: ARVN

Arvinas, Inc. (ARVN) Reports Q2 Loss, Misses Revenue Estimates

2 months ago - By: Daré Bioscience, Inc.

Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream

3 months ago - By: Daré Bioscience, Inc.

UPDATE - Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the Bar

3 months ago - By: Daré Bioscience, Inc.

Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the Bar

3 months ago - By: Daré Bioscience, Inc.

Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive

3 months ago - By: Daré Bioscience, Inc.

Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders

4 months ago - By: Zacks Investment Research - Mentions: BSX

Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?

5 months ago - By: Daré Bioscience, Inc.

Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update

5 months ago - By: Zacks Investment Research - Mentions: ACHC

Acadia Healthcare (ACHC) Beats Q1 Earnings Estimates

5 months ago - By: Zacks Investment Research - Mentions: CTKB

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Lags Revenue Estimates

5 months ago - By: Daré Bioscience, Inc.

Daré Bioscience to Host First Quarter 2025 Financial Results and Company Update Conference Call and Webcast on May 13, 2025

5 months ago - By: Daré Bioscience, Inc.

Daré Bioscience to Present at the Fierce Pharma Engage Summit on Breaking Barriers and Building Access: Communicating Bold Moves in Women’s Health Innovation

DARE BIOSCIENCE INC (DARE) Stock News

DARE Latest News, Press Relases and Analysis